Subcutaneous Abatacept in Patients With Polyarticular-Course Juvenile Idiopathic Arthritis : Results From a Phase III Open-Label Study

Brunner, Hermine I.;Tzaribachev, Nikolay;Vega-Cornejo, Gabriel;Louw, Ingrid;Ruperto, Nicolino;et.al.
(2018) Arthritis & Rheumatology — Vol. 70, n° 7, p. 1144-1154 (2018)

Files

SubcutaneousAbataceptinPatientsWithPolyarticularCourseJuvenileIdiopathicArthritis.pdf
  • Open Access
  • Adobe PDF
  • 727.45 KB

Details

Authors
  • Brunner, Hermine I.Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
    Author
  • Tzaribachev, NikolayPediatric Rheumatology Research Institute, Bad Bramstedt, Germany
    Author
  • Vega-Cornejo, GabrielHospital México Americano, Guadalajara, Mexico
    Author
  • Louw, IngridPanorama Medical Centre, Cape Town, South Africa
    Author
  • Lauwerys, BernardUCLouvain
    Author
  • Ruperto, NicolinoIstituto Giannina Gaslini, Genoa, Italy
    Author
Show more
Affiliations

Citations

Brunner, H. I., Tzaribachev, N., Vega-Cornejo, G., Louw, I., Berman, A., Calvo Penadés, I., Antón, J., Ávila-Zapata, F., Cuttica, R., Horneff, G., Foeldvari, I., Keltsev, V., Kingsbury, D. J., Viola, D. O., Joos, R., Lauwerys, B., Paz Gastañaga, M. E., Rama, M. E., Wouters, C., et al. (2018). Subcutaneous Abatacept in Patients With Polyarticular-Course Juvenile Idiopathic Arthritis : Results From a Phase III Open-Label Study. Arthritis & Rheumatology, 70(7), 1144-1154. https://doi.org/10.1002/art.40466 (Original work published 2018)